Whistleblower Law Insights

A survey by Corporate Board Member of more than 400 board members reveals that they are not huge fans of the whistleblower provisions of the Dodd-Frank Wall Street Reform and Consumer Protection Act. One...

A round of applause for Food and Drug Administration Deputy Chief for Litigation Eric Blumberg. He said yesterday at a conference in Washington that executives of pharma companies that promote off-label...

CHRISTUS Health, a Texas-based hospital chain, has agreed to pay almost $1 million to settle allegations that it committed Medicare fraud by falsely billing for unapproved medical costs and failing to...

Phillips & Cohen LLP, the nation’s most successful law firm representing whistleblowers, has been selected for the National Law Journal’s “Hot List” of the Top 12 plaintiffs’ law firms in...

The story of a stock trader who went undercover to help the FBI expose a Ponzi scheme shows some of the problems that have confronted the government even when it knows that a fraud is occurring. Ty Schlobohm...

Several large drug companies – including Merck & Co., AstraZeneca, Bristol-Myers Squibb, and GlaxoSmithKline – have said that they are being investigated for bribing government officials...

Novartis Pharmaceuticals Corporation has agreed to pay $422.5 million in two separate settlements resulting from their alleged off-label drug marketing. According to the accusation, Novartis profited by...

The Supreme Court has added two cases to its docket that will examine the possible limitations of the “sate secrets” doctrine. These cases involve Navy and military contractors whose contracts have...

The House of Representatives has passed a bill that would ban corporate executives from doing business with Medicare if their companies engaged in Medicare fraud – even if they left the companies before...

While the exchanges bicker over the cost of implementing real-time market tracking systems (“Charges Bring SEC Hope for New Weapon,” Wall Street Journal, Aug. 30), on-the-ground whistleblowers remain...